Granules India Ltd


very disappointing to say the least! clearly Pharma bull run is over for the time being.

Disc: Invested

(tankerooooo) #657

Granules QIP has closed. They have sold 2.47,54,792 shares at 121.25 per share for a gross amount of 300 cr.

BSE document link -

(tankerooooo) #658

Motilal Oswal report on Granules -

(Rohit Ojha) #659

Granules has got the approval for Prasugrel and they seem prepared to launch it anytime. It would be interesting to see how this first launch goes.


MOSL is promoting this stock aggressively.

(Marathondreams) #661

Motilal Oswal comes out with 100 bagger study and then goes out and promotes aggressively the stock listed in that study … I am sure it may be just a coincidence :wink:

(atishay1) #662

“Be fearful when others are greedy and be greedy when others are fearful”-- Easy to say, difficult to implement. Happy Diwali guys and wish more fortune during the year.

Discl. Recently exited (small allocation + no time to track ;no other reason)

(Sunday) #664

2017 Q2 Results are out.
Results are okay… nothing exceptional. Looks like we need to wait till Q3 results.
Investor earnings call -on 10th NOV.

(rpm) #665

Repeat performance requested from you for summary of con call.

(Sunday) #666

Highlights of Management interview with CNBC:

  • Required Capital Expenditure has been made and no further CAPEX for the next 3 to 4 years.
  • Current quarter had additional employee cost for the new facilities.
  • Second half especially the last quarter to see good revenue growth.
  • Owner has purchased more shares recently and would continue to purchase more when possible.
  • Only 15% of shares are pledged, rest have been released. This 15% would be released by next year.

(tankerooooo) #667

The short-term uncertainty with respect to the Omnichem JV is unfortunate. It is probably the cause for Granules stock price to drift down post-earnings.


(kauban) #669

thanks for the interview link. For me i heard 3 key points in the interview.

  1. No capex planned for the next 3 -4 yrs. If thats true then the operating leverage should start kicking in from FY19 onwards. Free cash flows hd start kicking in significantly.
  2. Promoter pledging has come down to ~ 15% of the company’s total no of shares from almost 35-36%. Plans to bring it down to zero by end of this year or worst at some time next year.
  3. Promoter has bought shares from the open market, so promoter holding has gone up a bit.

I think all 3 are positive moves for the company, although in the past for me constant dilution of equity by either QIP or Warrants to promoters has been an issue. The quality of the business was never a question due to the multiple growth levers available. If the mgmt delivers on the above 3 statements then there is scope for outperformance that many have been expecting from Granules.

(Mani) #670

Does anybody know the amount equity dilution since FY17 till now as a result of QIPs? (I recall they wanted to raise 500Cr via QIP post FY17…)

(Mani) #671

This is 11%. So I guess per guidance, all we can expect is an EPS increase of about 9-10% for FY18.


Q2 Concall Transcript

(rskothari) #674

Approval from US FDA for ANDA filed by Granules
Approval from US FDA.pdf (212.1 KB)

(mp bajaj) #675

Market size of Metformin ER tab? From which facility? Market has ignored this ANDA, why?
Promoter pledging has reached 78% now. Granules USA was supposed to have 1ANDA approved last month & another by March18.

(mrai74) #676

Despite larger indices are southward due to external / internal reasons, few scrips have managed to remain in green / stable but our company couldn’t hold despite bulk of good news in last 8-10 days

Does any one feel that to keep the average cost of acquisition down, the prices are managed. I don’t have proof or even don’t doubt integrity of promoters.

Anyone having similar view with more documentary proof are welcome

(Parag) #677

I think promoters have rejigged their shareholding and I believe Promoters have bought shares from other group company. But it looks like they have taken a huge loan as shown by below screenshot from the

If the market corrects further, which seems more probable now, promoters, who has pledged considerable shareholding may face trouble as they have to either pledge more and more share or sell shares in the market at a depressed price.

I do not remember exactly, how much promoters shareholding is pledged, but I think it will be substantial now taking into account that has pledge shares worth 784 cr at least. In my view this is negative for the company as a further correction in price could trigger force sell (may or may not).